HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure ProphylaxisVerena Muzio, Sheikh MF Akbar, Isabel Parejo González et al.|Euroasian Journal of Hepato-Gastroenterology|2021Cited by 12
HEPATITIS B NUCLEOCAPSID PARTICLE AS IMMUNOPOTENTIATOR OF INNATE AND ADAPTIVE IMMUNITY FOR NASAL VACCINES CIGB 2020 AND MAMBISA AGAINST COVID-19Gerardo Guillén, Estebán Martínez, Verena Muzio et al.|International Journal of Infectious Diseases|2023Cited by 0